Sporadic Parathyroid Adenoma: A Pilot Study of Novel Biomarkers in Females

Medicina (Kaunas). 2024 Jul 5;60(7):1100. doi: 10.3390/medicina60071100.

Abstract

Background and Objectives: Parathyroid adenoma is a distinct cause of primary hyperparathyroidism, with the vast majority being sporadic ones. Proteomic analysis of parathyroid adenomas has proposed a large number of related proteins. The aim of this study is to evaluate the immunohistochemical staining of ANXA2, MED12, MAPK1 and VDR in parathyroid adenoma tissue. Materials and Methods: Fifty-one parathyroid adenomas were analyzed for ANXA2, MED12, MAPK1 and VDR expressions. Tissue was extracted from formalin-fixed paraffin-embedded parathyroid adenoma specimens; an immunohistochemical study was applied, and the percentage of allocation and intensity were evaluated. Results: ANXA2 stained positively in 60.8% of all cell types, while MED12 had positive staining in 66%. MAPK1 expression was found to be negative in total, although a specific pattern for oxyphil cells was observed, as they stained positive in 17.7%. Finally, VDR staining was positive at 22.8%, based on nuclear staining. Conclusions: These immunohistochemical results could be utilized as biomarkers for the diagnosis of sporadic parathyroid adenoma. It is of great importance that a distinct immunophenotype of nodule-forming cells in a positive adenoma could suggest a specific pattern of adenoma development, as in hereditary patterns.

Keywords: ANXA2; MAPK1; MED12; VDR; immunohistochemistry; parathyroid adenoma.

MeSH terms

  • Adenoma*
  • Adult
  • Aged
  • Biomarkers / analysis
  • Biomarkers, Tumor / analysis
  • Female
  • Humans
  • Immunohistochemistry / methods
  • Middle Aged
  • Parathyroid Neoplasms* / pathology
  • Pilot Projects
  • Receptors, Calcitriol / analysis

Substances

  • Receptors, Calcitriol
  • Biomarkers, Tumor
  • Biomarkers
  • VDR protein, human

Grants and funding

This research received no external funding.